SKI Market

Indian Indices

Sensex

76,863.71 -1,342.27
( -1.72%)

Global Indices

Nasdaq

47,717.90 -43.91
(-0.09%)

Dow Jones

6,802.01 -14.98
(-0.22%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

92.14 0.30
(0.32%)

EUR-INR

106.58 -0.02
(-0.02%)

GBP-INR

123.09 0.04
(0.04%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

535469

INE0LA901015

11.3920003

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JFLLIFE

15.07

72.59

EPS(TTM)

Face Value()

Div & Yield %

0.73

Back

birla corporation ltd

National Standard (India) standalone net profit declines 11.25% in the September 2025 quarter

Oct 17,2025

Net profit of National Standard (India) declined 11.25% to Rs 4.26 crore in the quarter ended September 2025 as against Rs 4.80 crore during the previous quarter ended September 2024. Sales rose 353.95% to Rs 17.25 crore in the quarter ended September 2025 as against Rs 3.80 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	17.25	3.80	354
OPM %	-2.09	53.42	-
PBDT	5.83	6.40	-9
PBT	5.83	6.40	-9
NP	4.26	4.80	-11

76,863.71 -1,342.27 ( -1.72%)

47,717.90 -43.91 (-0.09%)

6,802.01 -14.98 (-0.22%)

55,018.23 769.84 (1.42%)

10,315.38 -96.86 (-0.93%)

92.14 0.30 (0.32%)

106.58 -0.02 (-0.02%)

123.09 0.04 (0.04%)

0.58 0.00 (0.05%)